Hospitalisations, admission costs and re-fracture risk related to osteoporosis in Western Australia are substantial: a 10-year review.
Introduction
Osteoporosis is a skeletal condition characterised by a decrease in bone mass and quality which reduces bone strength and increases propensity to fracture. The impact of osteoporotic fractures on people is substantial. They are associated with significant physical and psychological impacts 1 .
Mortality and morbidity associated with osteoporotic fractures, expressed as disability-adjusted life years (DALYs), exceed those for many other chronic health conditions 2 , representing a substantial personal and socioeconomic burden at a state level 3 , national level 4 , and globally 5 .
Although data from the last decade indicate the age-specific rate of fractures is declining in Western populations, including Australia, the absolute number of people who sustain fractures will increase in coming years as the population ages 4, 6 , increasing the burden of disease attributed to osteoporosis. Importantly, once an initial fracture is sustained (an incident fracture), the risk of refracture rises markedly, particularly in the first year 7 and exponentially for every subsequent fracture sustained thereafter 8, 9 . Therefore, the 'time to next fracture' represents an important window for preventive intervention to minimise a fracture cascade and improve health outcomes. In 2001, a hospitalisation for a fracture related to osteoporosis occurred every 8.1 minutes in Australia, increasing to every 5-6 minutes in 2007 and every 3.6 minutes in 2013. By 2022, the rate will increase to one fracture every 2.9 minutes 4 . More Australians sustaining more fractures, taken in parallel with increasing morbidity impacts and mortality risks associated with each fracture sustained, will undoubtedly place enormous pressure on our health systems, particularly emergency, radiology and orthopaedic surgery departments, and residential aged care facilities. It is critical, therefore, that effective, systemic reforms are initiated to deal with these projections 10, 11 .
At state jurisdictional levels, both Western Australia (WA) and New South Wales (NSW) have developed, through their Musculoskeletal Networks, evidence-informed Models of Care to deal with the impact of osteoporosis at a system-wide level 3, 10, 12 , particularly the re-fracture cascade. The principal recommendation from these Models of Care is to establish fracture liaison services (FLSs) within health systems, consistent with recent international position statements [13] [14] [15] . The role of FLSs is to coordinate the timely identification, assessment and appropriate multidisciplinary management of people who sustain incident osteoporotic fractures as a means to reduce the risk of recurrent fracture. Recent data from Australia and internationally substantiate the clinical efficacy and costeffectiveness of these services [16] [17] [18] . However, examining local system costs prior to the introduction of such system-wide reforms is necessary to determine local cost effectiveness of such initiatives and to provide relevant data to policy makers, including baseline metrics.
While the system impact of re-fractures has been modelled in NSW using data from three hospital sites 19 , no such data exist for WA. The NSW data identified an increase in the number of patients admitted for treatment of fractures over the last 5 years and that introduction of a FLS- Quantifying the cost burden associated with health conditions is complex and often requires multiple methodological assumptions, particularly related to indirect costs, which may lead to variable findings. For this reason, quantification of direct hospital costs may be preferable to derive an accurate, albeit non-exhaustive, cost burden 22 . These data are important to inform decision making regarding planning, resourcing and evaluating health service activity, particularly in the context of osteoporosis 22 . As a means to quantify the impact of osteoporotic re-fractures at a system-level, the aim of this study was to undertake an analysis of the occurrence of re-fractures due to osteoporosis requiring hospitalisation in WA over a decade. In particular, this study aimed to:
i) describe the number of hospitalisations, re-admissions, bed days and treatment costs incurred; ii) determine the time to first re-admission for osteoporotic fracture; and ii) estimate the risk of refracture due to osteoporosis over 10 years.
Methods
Study design and data extraction After extraction of all people ≥50 years with a hospitalisation due to osteoporotic fracture between broader criteria. Indeed, using broader criteria in this context is recommended 27 and our criteria were consistent with the method used in NSW 19 .
Patient characteristics (age at admission, gender) and hospitalisation details (other diagnoses, Diagnostic Related Groups (DRG), admission and separation dates) were extracted, consistent with methods reported previously 28 . Date of death data obtained from the WA Mortality Registry were used in the statistical analysis and linked to patients in the hospital data through the Data Linkage System.
Data analysis
Hospital separations associated with the same osteoporotic/low trauma fracture episode of care (including hospital transfers) were combined to avoid over-counting the number of re-admissions.
Costs and hospital bed days of transfer records were summed for the same episode. The costs were derived using National Public Cost Weight Tables which are based on DRGs. They were then adjusted for the Consumer Price Index (CPI) relative to 2011/12 financial year prices.
Cox proportional hazard models were used to assess factors influencing time to first re-admission for osteoporotic fracture including age, gender, bed days of the index episode and DRG-coded co-morbidities or therapies known to influence fracture risk; including diabetes, asthma, rheumatoid arthritis, thyroid and parathyroid disorders, malabsorption-related conditions, autoimmune diseases, chronic kidney and liver diseases, chemotherapy, adverse effects of glucocorticoids and androgen deprivation therapy. These predictor variables were selected a priori based on data available to us in the HMDS and clinically-meaningful factors. The co-morbidities and therapies were identified based on our clinical judgement and the available DRG codes. The time-to-event variable was the days from the index separation date to the first re-admission date for patients who had a readmission, or date of death for patients with no re-admission who died before the end of the study.
Patients with no re-admission or death during the study period were censored at 31 December 2011.
For Cox regression models only, a look-back period of 10 years prior to 1 January 2002 was undertaken to identify and remove patients who were admitted for an osteoporotic fracture (M80.x or equivalent ICD-9 code, 733.1x any diagnosis field) before 2002 to increase certainty that patients sustained their first (index) fracture during 2002-2011. While this approach does not provide absolute certainty that index admissions within the study period reflected first ever admissions for osteoporotic fractures sustained by individuals within the study period, it provides a level of increased assurance for the purposes of examining associations between index events and a prioridefined factors. The look-back was not applied to cost estimates as we sought to calculate the true system cost to WA over the decade, and thus, did not exclude cases for these estimates.
Kaplan-Meier curves were used to test whether the hazard for male and female remained proportional across the duration. A cross-over at approximately 2 years (782 days) suggested gender violated proportional hazard assumption. Consequently, the risk of re-admission between genders was compared in separate models, before and after the cross over point and for the whole study period. The interactions between risk factors and the log time-to-first re-admission were included in models to test proportional hazard assumptions for risk factors. When the assumptions were violated, the interaction terms were adjusted in the final model. All analyses were carried out in SAS enterprise guide 5.1.
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Results

Index and recurrent fractures and associated costs
During the study period (2002 -2011), 5,326 patients were admitted (index admissions) to WA hospitals due to an osteoporosis-related fracture; 1,155 were males (21.7%) and 4,171 were females (78.3%). 379 males (32.8%) and 1,658 females (39.8%) sustained at least one re-fracture episode, respectively, within the decade period (Table 1) .
Of the 2,037 (38.2%) patients who sustained a re-fracture requiring hospitalisation, 1,223 (23.0%) patients sustained one re-fracture episode, 453 (8.5%) sustained two re-fracture episodes, and 361 (6.8%) sustained three or more re-fracture episodes requiring readmission within the decade period.
A total of 3,646 re-admissions were observed during the 10 years (a mean of 1.8 readmissions per patient). The number of patients admitted for an index event decreased over the study period, while the number of re-admissions increased between 2002 and 2004 and then plateaued due to the limited observation period for patients who had an index fracture in later years of the decade studied (Table 1) .
A total of 75,182 bed days related to 3,646 re-admissions (average 20.6 bed days per re-admission)
was recorded. Despite the number of re-admissions plateauing after 2004, the bed days continued to increase. The average bed days per re-admission increased linearly over time. Table 1 provides summary statistics on re-admissions by year across the study period.
The total CPI-adjusted cost of the index hospitalisations due to osteoporotic fractures was $57,007,262 in the 10 years period (mean cost per patient $10,704). An additional $48,948,623 was associated with readmissions after the index hospitalisation (mean cost per patient $24,030) within the decade period. The total, mean and median costs per re-admission increased linearly over the decade after adjusting for the CPI (Table 1) .
Time between incident fracture and re-admissions
Of the 2,037 patients who were re-admitted for a re-fracture within the decade period, 44.4% were readmitted within less than 6 months, 13.1% within 6 months to <1 year, 17.4% within 1 to <2 years, 10.5% within 2 to <3 years, and 14.6% within 3 or more years of the index admission. Male patients had a higher proportion of re-admissions (56.7%) within the first 6 months than female patients (41.6%). years with a greater proportion of females readmitted. However, these trends observed before and after two-year cross-over point were not significant after adjusting for age, co-morbidities and bed days (using male as the reference HR=0.83, 95% CI = 0.61 -1.13; p=0.233 and HR=1.27, 95% CI = 1.00-1.69; p=0.098).
Risk of admission for re-fracture
The descriptive data summarised in Table 2 demonstrates female patients in the study were older than male patients. In both sexes, age was similar between patients with and without re-admissions.
The proportions of comorbidities among patients with and without re-admissions were also similar.
The risk of first re-admission for re-fracture among males increased by 3% and 5% for every one year increase in age and every additional bed day during the index admission, respectively. In males with asthma or adverse effects from glucocorticoids or androgen deprivation therapy, the risk of readmssion was approximately 2 or 3 times greater, respectively ( Table 2 ). The risk of first readmission for females increased by 3% for every additional bed day during the index admission. Age had no significant influence on the risk of first re-admission in females. Chronic liver disease was associated with an 51% increase in the risk of first re-admission for female patients ( Table 2) .
Discussion
Using linked-data, we have identified a substantial direct hospital cost to WA for low-trauma fractures related to osteoporosis, exceeding $AUD100 million over a ten year period. While this magnitude of cost is alarming, of greater concern is the observation that direct hospital costs per readmission for fracture increased in parallel with length of stay over the period. These data highlight the need for system reform initiatives to stem the flow of recurrent fractures among people with osteoporosis 11 . Our data suggest that 38% of patients with an index event are re-admitted for fracture(s) within a 10 year period and more than 50% of these re-admissions occur within the first year, highlighting this window as a critical period for preventive interventions.
Over the ten year period, we observed a linear decline in the incidence of index admissions. These trends, however, should be interpreted within the context of the definitions for index admissions and re-admissions used in this study. That is, index admissions refer to first admissions within the study period, not first ever admissions. It is likely, therefore, that many of the admission events The average cost per re-admission (CPI-adjusted for 2011/12 prices) rose linearly over the decade which is directly related to a progressively increasing length of stay for re-admissions. While we cannot infer causation for this observation, we speculate it may be due to cohort ageing and a potentially increasing co-morbidity burden over the decade. These data suggest it is critical, therefore, to initiate preventive interventions after incident fracture, particularly in elderly patients, given the trajectory of increasing costs for the state health system and benefits to the health of the individuals.
In both males and females, increasing length of stay during the index admission increased the risk of re-admission for re-fracture, suggesting that timely clinical attention to the index fracture event and other diagnoses associated with the index admission are important to improve outcomes. For example, time to surgical intervention for hip fracture exceeding 48 hours is associated with poorer outcomes 32 . Increased length of stay during an index admission may partly reflect the increased frailty and/or comorbidities in this cohort requiring pre-surgical optimisation and higher comorbid complications during their admission. In females, risk of re-admission was not influenced by age, suggesting that interventions in any female aged ≥50 years with osteoporotic fracture is important, particularly those with chronic liver disease. For males, increasing age was associated with readmission risk, highlighting the importance of clinical attention in elderly males with osteoporotic fracture. Similarly, increased vigilance is warranted in males with asthma or being treated with glucocorticoid or androgen deprivation therapies given that fracture risk associated with these agents is high and not necessarily commensurate with bone mineral density 33, 34 .
With an ageing population and potentially longer length of stay and escalating costs to manage fractures in an older, frailer demographic, more negative outcomes are likely when intervention strategies are delayed. Some strategies already in place go some way to address this such as falls prevention programs, subsidised access to screening and primary prevention pharmacotherapies.
However, these strategies have limited reach and efficacy and preventable fracture rates remain high, contributing to the enormous burden of disease imposed by osteoporosis. For example, falls were the leading cause of injury requiring hospitalisation in Australians aged 65 years and older in 2011-12 and fractures were the most common type of injury associated with a fall 35 .. In this study we observed that the majority of re-admissions occurred within the first year after the incident fracture, consistent with previously reported data 8 and likely reflects the immediate and substantial health impact of osteoporotic fractures. Timely identification of people sustaining incident fractures is therefore critical in the first year to avert downstream consequences of re-fracture.
Internationally, efforts are underway to implement systems to arrest the fragility fracture cycle, principally through the implementation of fracture liaison services. For example, the International Osteoporosis Foundation recently launched a report summarising contemporary international data on incident fracture rates, associated costs and re-fracture risks 15 .
A substantial strength of this study is the use of state-wide linked data. This approach ensured we accurately captured all index and re-admissions across all hospitals in WA within the ten year window of interest and represents a methodological advance over previous work 19 . The results reported here should be interpreted in the context of some methodological limitations. First, our case ascertainment was limited to people who were admitted to WA hospitals, and thus did not consider resource implications for fractures that did not come to clinical attention or those managed in primary care or in emergency departments. Second, our costs estimates were based on direct DRG-derived costs attributed to the hospital stay and therefore did not consider indirect costs, which are known to be substantial 4 . For example, in a recent modelling report, indirect costs of musculoskeletal diseases accounted for the majority (83%) of total costs to the Australian community in 2012 21 . Further, these DRG-derived costs related to the primary diagnosis field on the medical record. In circumstances where the primary diagnosis was not an osteoporotic fracture, the DRG-derived cost may over or under-estimate the cost attributed to the management of the osteoporotic fracture. This limitation is balanced somewhat by the fact that not all osteoporotic fractures coming to clinical attention are coded as such and therefore, we may underestimate the total system impact of these episodes of care. Future work could utilise the alternative methods for estimating unit costs that have been proposed more recently 4 , and could examine the relationships between fracture types and system outcomes. Finally, our definition for index admission referred to the first admission for an osteoporotic fracture within the study period. As such, index admissions don't necessarily reflect a true first admission for fracture, and therefore our observations in the initial years of the study period may underestimate the true rate of re-admissions and thus true readmission cost in the earlier years.
Conclusion
Osteoporotic fracture-related hospitalisations impose a substantial financial impact to WA, exceeding $AU100M in a decade. The risk of hospitalisation for re-fracture rises markedly after an index fracture, particularly within the first 12 months and particularly in high risk groups. These data provide further justification for the implementation of Fracture Liaison Services in health services. # Model adjusted for age and bed day interaction, no variables violated the proportional hazards assumption. The reference categories were patients who didn't have co-morbidities ‡ Model adjusted for age and bed day interaction as well as variables which violated the proportional hazards assumption including age, asthma and chronic kidney disease. The reference categories were patients who didn't have co-morbidities. ^ Identified at any hospital admission. *P<0.05.
Supplementary Material 1:
ICD-10-AM diagnosis and primary cause of injury codes used to select cases for a definition of minimal trauma fracture (MTF). To meet the criteria for MTF, separations needed to have one of the listed S or T diagnostic codes and one of the W mechanism of injury codes. 
